Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03925662

Mebendazole as Adjuvant Treatment for Colon Cancer

mebendazole treating colon cancer

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Colorectal Cancer Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

About this study

mebendazole as adjuvant treatment for colon cancer

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Colorectal cancer stage 4.

Exclusion criteria

  • Agranulocytosis
  • Pregnancy
  • Allergy to mebendazole.

Treatment and study plan

Folfox with avastin

Drug

Folfox with avastin only

Other names: folfox 4

Mebendazole

Drug

Folfox with avastin with mebendazole

Other names: mebendazol

Primary outcomes

  1. number of patients with tumour response

    Time frame: 6 months

    number of patients with response

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Sherief Abd-Elsalam

Other

Registry information

Official study title

Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer

Important dates

Study start
2019
Primary completion
2028
Study completion
2028
First posted
Apr 24, 2019
Registry last updated
Apr 24, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.